Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 17, 2023, titled “Glenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mg”…….
| Subscribe To Our Free Newsletter |
